Activated HER3 as a marker for predicting therapeutic efficacy

Details for Australian Patent Application No. 2007324868 (hide)

Owner U3 Pharma GmbH

Inventors Rothe, Mike; Treder, Martin

Agent Davies Collison Cave

Pub. Number AU-A-2007324868

PCT Pub. Number WO2008/064884

Priority 60/861,243 28.11.06 US; 06024658.4 28.11.06 EP

Filing date 28 November 2007

Wipo publication date 5 June 2008

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

4 June 2009 PCT application entered the National Phase

  PCT publication WO2008/064884 Priority application(s): WO2008/064884

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007324873-Device for conversion of thermodynamic energy into electrical energy

2007324850-Treatment for multiple myeloma